S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Sell every Stock except ONE (Ad)
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Sell every Stock except ONE (Ad)
Ruptured oil pipeline off California approved for repairs
Italy's Meloni vows to put national energy interests first
Sell every Stock except ONE (Ad)
Danes: Nord Stream 2 pipeline seems to have stopped leaking
Brazil holds historic election with Lula against Bolsonaro
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Sell every Stock except ONE (Ad)
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Sell every Stock except ONE (Ad)
Ruptured oil pipeline off California approved for repairs
Italy's Meloni vows to put national energy interests first
Sell every Stock except ONE (Ad)
Danes: Nord Stream 2 pipeline seems to have stopped leaking
Brazil holds historic election with Lula against Bolsonaro
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Sell every Stock except ONE (Ad)
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Sell every Stock except ONE (Ad)
Ruptured oil pipeline off California approved for repairs
Italy's Meloni vows to put national energy interests first
Sell every Stock except ONE (Ad)
Danes: Nord Stream 2 pipeline seems to have stopped leaking
Brazil holds historic election with Lula against Bolsonaro
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Sell every Stock except ONE (Ad)
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Sell every Stock except ONE (Ad)
Ruptured oil pipeline off California approved for repairs
Italy's Meloni vows to put national energy interests first
Sell every Stock except ONE (Ad)
Danes: Nord Stream 2 pipeline seems to have stopped leaking
Brazil holds historic election with Lula against Bolsonaro
NASDAQ:KRYS

Krystal Biotech - KRYS SEC Filings & 10K Form

$69.70
-0.86 (-1.22%)
(As of 09/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$69.42
$72.32
50-Day Range
$64.85
$82.40
52-Week Range
$38.86
$102.99
Volume
341,095 shs
Average Volume
179,534 shs
Market Capitalization
$1.79 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$104.40

Recent Krystal Biotech SEC Filings

DateFilerForm TypeView
08/18/2022
4:02 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2022
3:59 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2022
6:50 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/01/2022
3:18 PM
Krystal Biotech (Issuer)
Sutherland Everett Rand (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2022
7:41 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2022
3:20 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2022
7:26 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2022
3:19 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2021
3:33 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2021
7:07 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2021
3:39 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2021
10:39 AM
Krystal Biotech (Issuer)
ROSSI DINO A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2021
10:36 AM
JANNEY DANIEL (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2021
10:33 AM
Gangolli Julian S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2021
10:30 AM
Krystal Biotech (Issuer)
Mason Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2021
10:26 AM
Krystal Biotech (Issuer)
Marantz Jing L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2021
6:19 PM
Krystal Biotech (Issuer)
ORTH ANDREW C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2021
3:05 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2021
6:31 PM
Krystal Biotech (Issuer)
ORTH ANDREW C. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/10/2021
7:20 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2021
7:06 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/06/2021
3:32 PM
Krystal Biotech (Filer)
Form DEFA14A
04/06/2021
3:30 PM
Krystal Biotech (Filer)
Form DEF 14A
03/24/2021
6:00 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2021
7:42 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:40 PM
Krystal Biotech (Issuer)
Romano Kathryn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:39 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
7:15 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2021
3:27 PM
BAKER BROS. ADVISORS LP (Filed by)
Krystal Biotech (Subject)
Form SC 13G/A
02/12/2021
3:55 PM
Krystal Biotech (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G/A
02/05/2021
3:39 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2021
3:35 PM
Frazier Life Sciences IX, L.P. (Filed by)
Krystal Biotech (Subject)
Form SC 13G/A
02/02/2021
3:13 PM
Krystal Biotech (Filer)
Form 424B5
01/22/2021
3:51 PM
Krystal Biotech (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/07/2021
7:02 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2021
4:14 PM
Krystal Biotech (Issuer)
Marantz Jing L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
7:15 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2020
4:28 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2020
3:39 PM
Krystal Biotech (Filer)
Form 424B5
11/09/2020
7:32 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2020
3:06 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2020
5:35 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2020
7:10 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2020
7:43 PM
Krystal Biotech (Issuer)
ROSSI DINO A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
7:22 PM
Gangolli Julian S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
7:10 PM
JANNEY DANIEL (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2020
3:17 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2020
3:10 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2020
4:16 PM
Krystal Biotech (Filer)
Form 424B2
05/19/2020
4:01 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
3:28 PM
Krystal Biotech (Filer)
Form 424B5
05/14/2020
7:05 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2020
3:45 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2020
8:42 AM
Krystal Biotech (Filer)
Form S-3ASR
05/04/2020
7:05 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2020
4:12 PM
Krystal Biotech (Filer)
Form DEF 14A
03/18/2020
7:14 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2020
10:16 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2020
7:00 AM
Krystal Biotech (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2020
4:27 PM
Krystal Biotech (Issuer)
Romano Kathryn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2020
4:27 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
8:15 AM
Krystal Biotech (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G
02/14/2020
4:12 PM
Krystal Biotech (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G
02/14/2020
3:14 PM
BAKER BROS. ADVISORS LP (Filed by)
Krystal Biotech (Subject)
Form SC 13G/A
02/14/2020
3:13 PM
Krishnan Krish S (Filed by)
Krystal Biotech (Subject)
Form SC 13G/A
01/31/2020
5:37 PM
Chien Jennifer (Reporting)
Krystal Biotech (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/18/2019
4:56 PM
Krishnan Suma (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2019
3:05 PM
Krystal Biotech (Issuer)
Riley Antony A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2019
3:03 PM
Krishnan Krish S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
8:58 PM
Krystal Biotech (Filer)
Form 8-K/A
11/04/2019
7:01 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2019
7:00 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2019
7:06 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2019
4:23 PM
JANNEY DANIEL (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2019
11:01 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2019
8:23 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/27/2019
3:28 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2019
3:47 PM
Krystal Biotech (Filer)
Form 424B5
06/24/2019
3:34 PM
Krystal Biotech (Filer)
Form 424B5
06/24/2019
7:08 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2019
4:24 PM
Krystal Biotech (Issuer)
Riley Antony A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2019
2:34 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
4:15 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2019
8:20 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/15/2019
3:07 PM
Krystal Biotech (Filer)
Form DEFA14A
04/15/2019
3:03 PM
Krystal Biotech (Filer)
Form DEF 14A
03/25/2019
8:07 PM
Krystal Biotech (Issuer)
Riley Antony A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
5:06 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2019
8:36 AM
Krystal Biotech (Filer)
Form 424B5
03/12/2019
8:28 AM
Krystal Biotech (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2019
7:12 AM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2019
3:06 PM
Krystal Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2019
4:53 PM
Gangolli Julian S (Reporting)
Krystal Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
4:51 PM
Gangolli Julian S (Reporting)
Krystal Biotech (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/19/2019
3:44 PM
Krishnan Krish S (Filed by)
Krystal Biotech (Subject)
Form SC 13G/A
02/19/2019
3:40 PM
Krishnan Suma (Filed by)
Krystal Biotech (Subject)
Form SC 13G/A
02/14/2019
4:13 PM
Krystal Biotech (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G/A
02/14/2019
12:39 PM
Frazier Life Sciences IX, L.P. (Filed by)
Krystal Biotech (Subject)
Form SC 13G/A
02/13/2019
3:29 PM
BAKER BROS. ADVISORS LP (Filed by)
Krystal Biotech (Subject)
Form SC 13G
11/05/2018
9:20 AM
Krystal Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
This page (NASDAQ:KRYS) was last updated on 10/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.